INDYFINANCE
2026-10-08 UTC
 

ConocoPhillips (COP) research: valuation against peers, fundamentals over time, risk and news coverage

ChartVs peersValuationValue mapQuartersScaleMarginsTrajectoryCash qualityPer shareReinvestmentBalance sheetStreetRiskSeasonalityOur coverage

COP

ConocoPhillips
USD
129.84
+0.38% today
Market cap
—
P/E trailing
—
P/E forward
—
EV/EBITDA
—
Op margin
—
Rev growth
—
Div yield
—
Beta
—
52-week range85.66 – 141.221 report(s) in our archive
Price navigator — COP

No data in this window.

    INDY NEWS coverage of COP1

    Every report in our own archive tagged with this symbol, newest first — fetched from the archive alongside the market data.

    • BREAKING STORYBEARISH
      Analyst Desks Fan Out Across Biotech and Consumer as China Auto Demand Cracks

      Sell-side research activity clustered in clinical-stage biotech and consumer discretionary names, with upgrades for ConocoPhillips, SharkNinja, BridgeBio and Cogent offset by reductions at Middleby and Neurogene. The sharper signal came from China, where July passenger vehicle retail sales fell 20% year over year.

    Full archive search for COP

    Every figure on this page is fetched and computed in your browser from free public sources — end-of-day prices and reported financials from Yahoo Finance's open endpoints, and our own archive for the coverage panel. Fundamental history on the free tier runs about four fiscal years and five quarters. Data is best-effort and unaudited; this is market research, not investment advice.

    Guidance reliability · COPmethodology·all companies

    ConocoPhillips does not put numeric guidance in its earnings releases.

    We read every quarterly earnings release COP has filed with the SEC since 2021 and found no forecast expressed as a dollar figure or a range of dollar figures. That is a real and fairly common practice — some managements guide only in percentage growth terms, some guide only on the earnings call, and some decline to guide at all. It is recorded here as an absence, not as a gap in our coverage.

    Next report expected 05 Nov 2026 (Q3 FY2026) — Estimated from the issuer's own filing history: FY2025Q3 results were released on 2025-11-06. source

    Coverage universe: S&P 100. This is a factual record of what a company forecast and what it then reported. It is not investment advice, and it is not a view on the company’s prospects — we publish the measurement and draw no conclusion from it.